Home > Result Summaries: Compounds > Dutasteride > Result Summary for 101722

Result Summary for 101722

Result Summary
Protocol ID: 101722
Clinical Study ID: 101722
Official Title: Prospective, national, multicentre, non comparative study evaluating the improvement of urinary symptoms, discomfort and quality of life in subjects with benign prostatic hyperplasia (BPH) after 24 weeks of treatment by dutasteride.
Phase: Phase 4
Study Indications or Diseases:
  • Prostatic Hyperplasia
Generic Name: dutasteride
Trade/Product Name: Duagen,Zytefor,Avolve,Avodart,Avidart,Zyfetor
Approved Drug Label: http://www.gsk.com/products/prescription-medicines/index.htm
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:
  • Desgrandchamps F, Droupy S, Irani J, Saussine C, Comenducci A. Effect of dutasteride on the symptoms of benign prostatic hyperplasia, and patient quality of life and discomfort, in clinical practice. BJU International 2006; 98(1): 83-88